A Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With Acromegaly

Condition:   Acromegaly Interventions:   Drug: CAM2029 (octreotide subcutaneous depot);   Drug: Matching placebo Sponsor:   Camurus AB Recruiting

Source: ClinicalTrials.gov - September 2, 2019 Category: Research Source Type: clinical trials